Full-Time
Posted on 10/1/2025
Telehealth obesity treatment with FDA meds
$180k - $220k/yr
San Francisco, CA, USA
In Person
In-person position, requires working five days a week.
Mochi Health provides telehealth obesity treatment with personalized care using FDA-approved medications. Patients join a subscription that includes medical consultations and prescribed therapies, with options for cost-effective compounded generics. It focuses on underserved groups such as the uninsured, people facing language or cultural barriers, and residents of rural areas to remove access barriers in care. The goal is to make effective obesity treatment accessible and affordable by bundling ongoing care with affordable medication options.
Company Size
N/A
Company Stage
Seed
Total Funding
$550K
Headquarters
San Francisco, California
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Commuter Benefits
Mochi Health Launches Insurance-Based Plans, Expanding Access to Personalized Obesity Care with Behavioral Therapy. by Jasmine Pennic 05/27/2025 Leave a Comment. What You Should Know: – Mochi Health, a physician-guided obesity care program, announced the launch of its new insurance-based plans. – These expanded offerings are designed to provide more personalized treatment experiences for patients, placing a strong emphasis on comprehensive obesity care that spans all aspects of an individual’s health. – The new insurance-based plans are available as an optional upgrade to Mochi’s existing offerings. They provide patients with access to either brand-name or compounded weight loss medication prescriptions, alongside routine video consultations with both a physician and a registered dietitian.Addressing a Growing National Health ConcernThe launch comes at a time when nearly three-quarters of U.S. adults are classified as overweight or obese, and approximately one in eight Americans are reportedly using GLP-1 medications for weight loss, underscoring the significant demand for effective solutions. Mochi Health’s expanded offerings aim to meet this need by blending personalized care with comprehensive support, recognizing that effective treatment must be tailored to the individual.Expanding Access to Comprehensive, Personalized Weight Loss SolutionsMochi Health’s new plans aim to cater to the unique needs of each individual navigating their weight loss journey
Eli Lilly sues Mochi Health and others for 'deceptive' tirzepatide marketing.